Multicentre UK study finds new blood test could detect the return and spread of breast cancer on average 10.7 months before tumours became visible on scans or patients developed symptoms

A new blood test for women with breast cancer can predict how well patients will respond to a new drug right at the start of treatment.

Combining a targeted drug with hormone therapy substantially extends survival for women with advanced breast cancer, a major clinical trial has found.